ECM
EagleClaw Capital Management’s Sanofi SNY Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $2.54M | Buy |
52,585
+6,760
| +15% | +$327K | 0.38% | 67 |
|
2025
Q1 | $2.54M | Buy |
45,825
+2,175
| +5% | +$121K | 0.4% | 70 |
|
2024
Q4 | $2.11M | Buy |
43,650
+375
| +0.9% | +$18.1K | 0.33% | 76 |
|
2024
Q3 | $2.49M | Buy |
43,275
+925
| +2% | +$53.3K | 0.42% | 69 |
|
2024
Q2 | $2.05M | Buy |
42,350
+975
| +2% | +$47.3K | 0.37% | 72 |
|
2024
Q1 | $2.01M | Buy |
41,375
+900
| +2% | +$43.7K | 0.36% | 74 |
|
2023
Q4 | $2.01M | Buy |
40,475
+7,175
| +22% | +$357K | 0.42% | 70 |
|
2023
Q3 | $1.79M | Buy |
33,300
+550
| +2% | +$29.5K | 0.41% | 72 |
|
2023
Q2 | $1.77M | Buy |
32,750
+1,300
| +4% | +$70.1K | 0.41% | 71 |
|
2023
Q1 | $1.71M | Buy |
+31,450
| New | +$1.71M | 0.4% | 69 |
|